Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 Rearrangement
Cheng‐Han Lee(National Tsing Hua University), Marisa R. Nucci(Brigham and Women's Hospital), Rola H. Ali(University of British Columbia), Matt van de Rijn(Stanford University), C. Blake Gilks(Vancouver General Hospital), Adrián Mariño‐Enríquez(Harvard University Press), Samuel Leung(BC Cancer Agency), Mei‐Jun Zhu(Washington State University), Esther Oliva(Agostino Gemelli University Polyclinic), Alayne Brunner(OncoMed (United States)), Torsten O. Nielsen(University of British Columbia), Paola Dal Cin(Brigham and Women's Hospital), Nataliya Nelnyk(BC Cancer Agency), David G. Huntsman(BC Cancer Agency), Xiangqian Guo(Stanford Medicine), Sarah Chiang(Memorial Sloan Kettering Cancer Center), Jonathan A. Fletcher(Harvard University), Marjan Rouzbahman(University Health Network)
Cited by 199
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
|Clinical Cancer Research|2008|1.2k